DIA 2020 Virtual Global Annual Meeting: Directory

Danielle Abatemarco

Bristol Myers Squibb

WWPS Innovation & Publications Management

SA

Stephanie Abbott

Western Washington Medical Group

Director of Research

Anna Adams

Medicines and Healthcare products Regulatory Agency (MHRA)

Senior GPvP Inspector, Inspection, Enforcement and Standards

AA

Adebola Adedimeji

Albert Einstein College of Medicine

Associate Professor of Epidemiology and Population Health

Joan Affleck

Merck & Co., Inc.

Executive Director, Head of Medical Writing

Kaia Agarwal

PharmApprove, A Member of the NDA Group

Strategic Lead

Dean Aguiar

Tuberous Sclerosis Alliance

Director, Preclinical Research

Shazia Ahmad

UBC

Director, Patient & Physicians Services

IA

Imad Al-Dakkak

Huron Consulting Group

Director

Rinol Alaj

TransCelerate Biopharmaceuticals

Director, COA and Innovation, Regeneron; Representative

AA

Albert Allen

Eli Lilly and Company

Senior Medical Fellow, Pediatric Capabilities

Jeff Allen

Friends of Cancer Research

President and Chief Executive Officer

Mitzi Allred

Merck Sharpe & Dohme, Co., Inc.

Director Clinical Operations; Head, Clinical Content Standards

Dawn Anderson

Deloitte

Managing Director

Jonathan Andrus

Clinical Ink

Chief Business Officer

Kristin Anthony

PTEN Hamartoma Tumor Syndrome Foundation

President

Yoko Aoi

Pharmaceuticals and Medical Devices Agency (PMDA)

Principal reviewer, Office of New Drug V

John April

Eli Lilly & Company

Content Strategy Advisor, Global Scientific Communications

Hiroyuki Arai

Pharmaceuticals and Medical Devices Agency (PMDA)

Director of Center for Product Evaluation and Center of Regulatory...

RR

Rajeswara Rao Arasada

The Ohio State University

MACPR Student

CA

Christine Årdal

Norwegian Institute of Public Health

Senior Advisor

Lauri Arnstein

Envision Pharma Group

Patient Partnership Liaison

Vinod Arora

Syneos Health

Associate Director, Consulting

Stacey Arrambide

Advanced Clinical

Senior Vice President, Functional Service Solutions

Christopher Austin

National Institutes of Health (NIH)

Director, National Center for Advancing Translational Sciences

Mark Avigan

FDA

Associate Director, Office of Pharmacovigilance and Epidemiology,...

Kassa Ayalew

FDA

Branch Chief, Office of Scientific Investigations, Office of...

Ryan Baehl

Covance

Vice President of Global Operations for CLS

PB

Pavel Balabanov

European Medicines Agency

Head of Therapies for Neurological and Psychiatric Disorders

Venkatraman Balasubramanian

Orion Business Innovation

Senior Vice President, Life Sciences

Matt Baldwin

Advance Research Associates, Inc (ARA)

Senior Biostatistician

Greg Ball

Merck & Co., Inc

Senior Principal Biostatistician

Phil Ball

Independent Consultant

Health Policy, Biopharmaceutical Development Strategy

Deepak Bandyopadhyay

Janssen

Associate Director, Quality Analytics

Mark Barnes

Ropes & Gray, LLP

Partner

Carla Barrett

PRA Health Sciences

Sr Director, Patient Safety Risk Mgmt

Merith Basey

Universities Allied For Essential Medicines (UAEM)

Executive Director, North America

Marilena Bassi

Health Canada

Senior Executive Director, Therapeutic Products Directorate

Steven Beales

ePharmaSolutions, a WIRB-Copernicus Group Company

Senior Vice President, Scientific and Regulatory

Steven Beales

WCG

Senior Vice President, Scientific & Regulatory Review

Matt Becker

SAS Institute Inc

Advisory Industry Consultant

Emmanuel Belabe

ArisGlobal

Associate Vice President, Safety

Kimberly Belsky

Mallinckrodt Pharmaceuticals

Executive Director, Regulatory Policy and Intelligence, Regulatory...

JB

Jasmine Benger

CISCRP

Research Services Senior Project Manager

Tyler Benning

Mayo Clinic

Medical Student

Robyn Bent

FDA

Director, PFDD Program, OCD, CDER

Aaron Berger

UBC

Senior Director, Real World Evidence

EB

Elise Berliner

Agency For Healthcare Research and Quality (AHRQ)

Director, Technology Assessment Program

AB

Aaron Bernstein

Aaron Bernstein Consulting, LLC

Principal

Michael Berntgen

European Medicines Agency

Head of Scientific Evidence Generation Department

Amy Bertha

Bayer

Senior Director, Regulatory Policy

Melanie Bhatnagar

FDA

Associate Director for Pediatric Education & Outreach, OPT, OC

Barbara Bierer

Harvard Medical School

Faculty Director, MRCT Center; Professor of Medicine

Claire Blanchette

Bayer

Vice President, Program Management - Oncogenic Signaling

Michael Blum

FDA

Deputy Director, Office of Pharmacovigilance and Epidemiology, CDER

Ashley Boam

FDA

Director, Office of Policy for Pharmaceutical Quality, OPQ, CDER

Mariette Boerstoel-Streefland

Alexion Pharmaceuticals, Inc.

Senior Vice President Global Drug Safety

Sébastien Bohn

IBM Watson Health

Offering Manager Executive

CB

Christopher Boone

Abbvie

Vice President, Global Head, Health Economics and Outcomes Research

Poonam Bordoloi

Merck & Co., Inc.

Director, Medical Affairs Team Lead

Vanessa Boulanger

National Organization for Rare Disorders (NORD)

Director of Research Programs

Linda Bowen

Seattle Genetics

Head of Regulatory Policy and Intelligence

David Bowers

PPD

Director, Medical Communications

Jim Box

SAS Institute Inc

Principal Data Scientist

Brian Bradbury

Amgen, Inc.

Executive Director, Head, Data and Analytics, Center for...

KB

Kate Bradford

Arena Pharmaceuticals

Head of International Field Based Medicine

Sonja Brajovic

FDA

Medical Officer, OSE, CDER

Jennifer Brandl

Kezar Life Sciences

Senior Clinical Trial Manager

KV

Kim Van Naarden Braun

Bristol-Myers Squibb Company

Associate Director, Translational Epidemiology, Informatics and...

Andrew Briggs

London School of Hygiene and Tropical Medicine (LSHTM)

Professor of Health Economics

Rachel Brodie

Pacific Business Group on Health

Senior Director, Measurement and Accountability

Philip (P.J.) Brooks

National Center for Advancing Translational Sciences (NCATS), NIH

Program Director, Office of Rare Diseases Research

Sam De Brouwer

doc.ai

Cofounder and COO

Daniela Brunner

Science Forward/PsychoGenics

Founder/CIO

GB

Gillian Buckley

The National Academies of Sciences, Engineering, and Medicine

Senior Program Officer, Health and Medicine Division

Michael Buckley

Memorial Sloan Kettering Cancer Center

Manager, Clinical Research Informatics and Technology Enterprise...

Joan Buenconsejo

AstraZeneca

Senior Director, Biostatistics

Kevin Bugin

FDA

Director of Special Programs, Office of New Drugs, CDER

Magda Bujar

Centre For Innovation In Regulatory Science (CIRS)

Manager, Strategic Development

Kristin Bullok

Eli Lilly and Company

Benefit-Risk Management Scientist, Global Patient Safety

Brandon Burch

Nuventra, Inc.

Associate Director, Scientific Writing and Regulatory Affairs

Jennifer Burgess

TransCelerate BioPharma Inc.

Vice President, Global Engagement and Communications

SB

Scott Burian

Rho, Inc.

Senior Scientist

Victoria Burk

AbbVie, Inc.

Senior Director R&D Quality Assurance

LB

Lisa Burke

Rhythm

Senior Director, Field Medical

David Burrow

FDA

Director, Office of Scientific Investigations, OC, CDER

Bill Byrom

Signant Health

Vice President, Product Strategy and Innovation

Gina Calarco

Covance

Director of Pediatric Strategy and Planning

Susan Callery-D'Amico

AbbVie, Inc.

Vice President, R&D Quality Assurance

Michelle Campbell

FDA

Senior Clinical Analyst for Stakeholder Engagement, DNP, OND, CDER

Susan Cantrell

Academy of Managed Care Pharmacy (AMCP)

Chief Executive Officer

Yi Cao

National Medical Products Administration (NMPA)

Deputy Division Director, Div 4, Center for Food and Drug Inspection...

Katherine Capperella

Janssen Pharmaceutical Companies of Johnson & Johnson

Global Patient Engagement Leader

NC

Nicholas Cappuccino

Dr. Reddy's Laboratories

Consultant, Compliance, Quality and Scientific Affairs

LC

Luca Cariolato

UBC

Senior Safety Scientist

Gillis Carrigan

Amgen

Director, Center for Observational Research

Suzanne Caruso

WCG

Vice President, Clinical Solutions

Nina Cauchon

Amgen

Director Regulatory Affairs CMC

Patrizia Cavazzoni

FDA

Director, Center for Drug Evaluation

Catherine Celingant

Pfizer Inc

Oncology Therapeutic Area Lead, Data Monitoring and Management (DMM)

Aloka Chakravarty

FDA

Deputy Director, Office of Biostatistics, Office of Translational...

Meghana Chalasani

FDA

Senior Research Analyst, Office of the Center Director, CDER

KC

Karen Chan

University of Southern California

Pharmacy Student

MC

May Chan-Liston

BMS

Global Risk Management Lead, Hematology and Cell Therapy

Andrew Chang

Novo Nordisk

Vice President, Quality and Regulatory Compliance

Lien-Cheng Chang

TFDA

Section Chief, Division of Medicinal Products

Pascal Chanu

Genentech, A Member of the Roche Group

Modeling and Simulation Expert

She-Chia Chen

FDA

ORISE Fellow, Office of Medication Error Prevention & Risk...

Ta-Jen Chen

FDA

Project Management Officer, OSP, CDER

Yeh-Fong Chen

FDA

Mathematical Statistician (Team Lead), Office of Translational...

Monica Chiaramonte

AstraZeneca

Medical Communications Scientist

Karla Childers

Johnson & Johnson

Senior Director, Strategic Projects, Office of the Chief Medical...

Jennifer Christian

IQVIA

Vice President, Clinical Evidence and Epidemiology

Leah Christl

Amgen

Executive Director, Global Regulatory and R&D Policy

David Churchward

Medicines and Healthcare products Regulatory Agency (MHRA)

Deputy Unit Manager, Inspectorate Strategy and Innovation (Expert GMP...

Antony Chuter

Independent

Patient Champion

JC

Jennifer Clark

FDA

Mathematical Statistician, OB, OTS, CDER

Aria Cohen

Apellis Pharmaceuticals

Senior Director, US Market Access

Evi Cohen

Appian

Vice President, Global Life Sciences & Healthcare

Oren Cohen

Covance

Chief Medical Officer and Head of Clinical Pharmacology Services

Ellen Coleman

VOZ Advisors

President and CEO

Susan Colilla

Teva Pharmaceuticals

Director and Lead, Epidemiology and RWE

Sylva Collins

FDA

Director, Office of Biostatistics, OTS, CDER

Seya Colloud

F. Hoffmann-La Roche Ltd

Global Regulatory Director

Deborah Collyar

Patient Advocates In Research (PAIR)

President

Michael Colopy

UCB Biosciences

Safety Statistics and Decision Scientist

VC

Vivian Combs

Eli Lilly and Company

Advisor/Process Owner, Clinical Systems and Supply Planning

SC

Sabrina Comic-Savic

The Medicines Company

Vice President, Quality Assurance, Clinical Project Oversight

Gary Condran

Health canada

Manager, Generic Drugs Quality Division, Bureau of Pharmaceutical...

Freda Cooner

Amgen

Director, Statistical Innovation

Stephen Joel Coons

Critical Path Institute

Executive Director, PRO Consortium

Fernanda Copeland

AVROBIO, Inc

Executive Director, Global Head of Patient Advocacy and Engagement

Charline Coquerel

Novo Nordisk A/S

Director, Global Patient Relations

MC

Madeline Corrigan

SmithSolve

Senior Account Manager

Christine Crandall

GlaxoSmithKline

Head of Clinical Project Management

Stephanie Crawford

University of Illinois at Chicago

Professor, Pharmacy Systems, Outcomes and Policy

Donatello Crocetta

Takeda Pharmaceuticals International Gmbh

Global Medical Head, Rare Immunology and Rare Metabolic Franchises

Alysha Croker

Health Canada

Manager, Office of Paediatrics and Patient Involvement

Michelle Crouthamel

AbbVie, Inc.

Director of Digital Health and Innovation

William Crown

Optumlabs

Chief Scientific Officer

JC

Jonathan Crowther

Pfizer Inc

Director, Site Intelligence

Linda Danielson

IDDI Inc

Chief Operating Officer and Executive Vice President

Ebony Dashiell-Aje

Biomarin Pharmaceutical Inc.

Director, Patient-Centered Outcomes Research

Ruthie Davi

Acorn AI, a Medidata Company

Vice President, Data Science

Jeannie David

FDA

Senior Program Management Officer, Drug Shortage Staff, CDER

Patricia Davies

Parkinson's Foundation

Reasearch Advocate

Larry Davis

EVERSANA

Vice President, Medical and Clinical Affairs

Susan DeHaven

Sanofi

Director, Data Standards and Business Applications

Richard Dennett

PPD

Senior Director Regulatory Affairs CMC

Corey Dennis

Sanofi

Lead, US Privacy Officer

Frederick Derosier

Covance

Executive Director, Rare Diseases

SD

Sameen Desai

Bristol Myers Squibb

Senior Director, Pharmacovigilance Innovation

Shyam Deval

Boston Technology Corporation

President

Robert DiCicco

IBM Watson Health

Deputy Chief Health Officer

Michael DiMaio

Ropes & Gray LLP

Attorney

Arielle Dipasquale

Rutgers, The State University of New Jersey

PharmD Candidate, Class of 2021, Ernest Mario School of Pharmacy

Rachael DiSantostefano

Janssen Research & Development, LLC

Senior Director, Benefit Risk / Epidemiology

SD

Sahith Doppalapudi

Bristol Myers Squibb

Manager, Safety Data Management and Analytics

Brian Dow

Janssen Research & Development, LLC

Scientist, Dossier Development and Operations

AnnCatherine Downing

Eli Lilly and Company

Senior Research Advisor - Clinical

Nicholas Drago

Bayer

Associate Director, Regulatory Policy and Intelligence

Nancy Dreyer

IQVIA

Chief Scientific Officer and Senior Vice President

BD

Brian Dreyfus

Bristol-Myers Squibb

Director

João Duarte

Alexion Pharmaceuticals

Director, Chief of Staff & Regulatory Science

David Dubin

AliveandKickn

Founder

DD

David Dubinsky

Blueprint Medicine

Head of Global Patient Affairs

Susan Duke

FDA

Mathematical Statistician, OB, OTS, CDER

Shalini Dwivedi

Syneos Health

Director, Consulting

Fabian D'Souza

Boston Strategic Partners, Inc.

Founder and President

Edye Edens

First Class Solutions, Inc.

Senior Research Compliance Consultant

Brian Egan

TransCelerate BioPharma Inc.

Engagement Manager

Falk Ehmann

European Medicines Agency

Chair of Innovation Task Force

Lukas Eichmann

Novo Nordisk

Associate Patient Relations Manager

Mary Elmer

Merck & Co., Inc.

Executive Director, Patient Innovation Organization

Jeff Elton

Concerto HealthAI

Chief Executive Officer

M. Khair ElZarrad

FDA

Deputy Director, Office of Medical Policy, CDER

Sonya Eremenco

Critical Path Institute

Associate Director, PRO Consortium, and Acting Director, ePRO...

Karen Erickson

Patient Advocate

CTTI Steering Committee Member

Sini Eskola

European Federation of Pharmaceutical Industries and Associations (EFPIA)

Director Regulatory Affairs

Harmonie Etienne

Dr. Ebeling & Assoc. GmbH

Pharmacovigilance Advisor

KE

Kathryn Evans

Analgesic Solutions

Research Associate

JF

John Farley

FDA

Deputy Director, Office of Antimicrobial Products, OND, CDER

Federico Feldstein

Johnson & Johnson

Vice President, Head of R&D Quality Compliance

Kristen Felthousen

University of Southern California School of Pharmacy

Program Administrator, Department of Regulatory and Quality Sciences

Phyllis Ferrell

Eli Lilly and Company

Global Head, External Engagement, Alzheimer's Disease and...

AF

Amy Fesmire-Baus

Bristol-Myers Squibb Company

Senior Medical Writer

DF

Daniel Fiebig

Rutgers University

Faculty

Ron Fitzmartin

FDA

Senior Informatics Advisor, Office of the Director, CBER

RF

Robert Fontana

University of Michigan

Professor of Medicine

Gail Francis

Medicines and Healthcare products Regulatory Agency (MHRA)

Expert Inspector, GCP

Celeste Frankenfeld

Merck & Co., Inc.

Associate Director

Emily Freeman

Sanofi

Senior Director, Global Regulatory Behavioral Science

David Fryrear

Astellas

Senior Vice President and Head of Clinical and Research QA, Medical...

Yasuhiro Fujiwara

Pharmaceuticals and Medical Devices Agency (PMDA)

Chief Exective

Andrea Furia-Helms

FDA

Director, Patient Affairs Staff, OC

MS

M. Scott Furness

FDA

Deputy Director

Sandra Gallagher

Viela Bio

Director of Project Management

Laura Galuchie

Merck & Co., Inc. (MSD outside US and Canada)

Director, Global Clinical Trial Operations

Shelley Gandhi

NDA Group

Strategic Advisor, Pharmacovigilance and Drug Safety

CG

Carlos Garner

Eli Lilly and Company

Vice-President Global Regulatory Affairs